An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe".
Mark Jit 
;
Marie-Josée J Mangen;
Hugues Melliez;
Yazdan Yazdanpanah;
Joke Bilcke;
Heini Salo;
W John Edmunds ;
Philippe Beutels;
(2010)
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe".
Vaccine, 28 (47).
pp. 7457-7459.
ISSN 0264-410X
DOI: 10.1016/j.vaccine.2010.08.060
;
Marie-Josée J Mangen;
Hugues Melliez;
Yazdan Yazdanpanah;
Joke Bilcke;
Heini Salo;
W John Edmunds ;
Philippe Beutels;
(2010)
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe".
Vaccine, 28 (47).
pp. 7457-7459.
ISSN 0264-410X
DOI: 10.1016/j.vaccine.2010.08.060
A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices.
Full text not available from this repository.
Downloads